Cross-Sector entity
That works out to roughly 4.5 stories per week across an 11-day span. The busiest single day carried 3. Of the tracked stories, 3 of 7 also mention Aquestive Therapeutics, Inc., the most common co-covered peer. corporate-law accounts for 3 of the 7 tracked stories, while 3 other categories carry the remainder.
7 verified stories tracked
Last mentioned: Mar 23, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 43 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
That works out to roughly 4.5 stories per week across an 11-day span. The busiest single day carried 3. Of the tracked stories, 3 of 7 also mention Aquestive Therapeutics, Inc., the most common co-covered peer. corporate-law accounts for 3 of the 7 tracked stories, while 3 other categories carry the remainder. Trip.com Group Limited appears in 7 tracked Cross-Sector stories published from March 13, 2026 through March 23, 2026. 43% of these stories carry negative sentiment. The tracked stories average 2.6 original sources each.
Computed from the 7 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Trip.com Group Limited. Shared-story counts are live from our verified record — not editorial picks.
Lead Plaintiff Deadline
The final date for investors to move the court to serve as lead plaintiff in the litigation.
Snowflake Filing
Pomerantz LLP issues formal notice of class action filing against Snowflake Inc.
Lawsuit Announcement
Kessler Topaz Meltzer & Check, LLP informs investors of the filed class action.
Class Period Ends
The final date of the alleged period of material misstatements and omissions.
Class Period Begins
The start date for investors eligible to join the securities fraud class action.
Trip.com Group Limited is the subject of a class-action lawsuit alleging material misstatements regarding its business practices and monopolistic activities between April 2024 and January 2026. Investors who suffered losses have until May 11, 2026, to seek lead plaintiff status in the litigation filed in the Eastern District of New York.
Trip.com Group Limited (NASDAQ: TCOM) is the target of a securities fraud class action lawsuit alleging material misstatements regarding its business practices and monopolistic activities. Investors who purchased securities between April 2024 and January 2026 have until May 11, 2026, to seek lead plaintiff status in the litigation.
Trip.com Group Limited (NASDAQ: TCOM) is facing a securities fraud class action lawsuit in the U.S. District Court for the Eastern District of New York. The litigation alleges the company made material misstatements and failed to disclose monopolistic business activities between April 2024 and January 2026.
Source: prnewswire.com · PR Newswire (us)
Pomerantz LLP has initiated a series of class action filings against Gartner, Trip.com, and Snowflake, alleging violations of federal securities laws. These legal actions target corporate transparency and disclosure practices, signaling a heightened period of scrutiny for high-growth tech and consulting firms.
Source: pr-inside.com · pr-inside.com
Pomerantz Law Firm has issued urgent reminders for investors regarding class action lawsuits against Trip.com Group, Aquestive Therapeutics, and Driven Brands Holdings. These legal actions focus on alleged securities violations and material misrepresentations that resulted in significant shareholder losses.
Pomerantz Law Firm has issued a formal reminder to Aquestive Therapeutics (AQST) investors regarding an ongoing class action lawsuit following a period of financial underperformance. The litigation coincides with a recent quarterly earnings miss and notable insider selling, creating a challenging regulatory and legal environment for the biotech firm.
Pomerantz Law Firm has issued urgent reminders to investors regarding upcoming lead plaintiff deadlines in class action lawsuits against Trip.com Group Limited, Driven Brands Holdings Inc., and Aquestive Therapeutics, Inc. These legal actions allege violations of federal securities laws, primarily focusing on misleading statements or omissions that resulted in significant financial losses for shareholders.
Source: prnewswire.com · prnewswire.com
